Severe heart failure: balancing length and quality of life.
D000676:Amrinone / Q000009:adverse effects; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D020105:Milrinone / Q000009:adverse effects; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects; D011719:Pyrazines; D011788:Quality of Life; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects*
D002316:Cardiotonic Agents; D010726:Phosphodiesterase Inhibitors; D011719:Pyrazines; D011804:Quinolines; C041667:vesnarinone; D020105:Milrinone; D000676:Amrinone